These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Therapeutic immunomodulation in neurology: from hope to reality. Exemplified by multiple sclerosis]. Schluep M, Regli F. Praxis (Bern 1994); 1995 Sep 19; 84(38):1021-4. PubMed ID: 7481299 [Abstract] [Full Text] [Related]
23. Three or more routes for leukocyte migration into the central nervous system. Ransohoff RM, Kivisäkk P, Kidd G. Nat Rev Immunol; 2003 Jul 19; 3(7):569-81. PubMed ID: 12876559 [Abstract] [Full Text] [Related]
25. The destructive alliance: interactions of leukocytes, cerebral endothelial cells, and the immune cascade in pathogenesis of multiple sclerosis. Minagar A, Carpenter A, Alexander JS. Int Rev Neurobiol; 2007 Jul 19; 79():1-11. PubMed ID: 17531835 [Abstract] [Full Text] [Related]
27. The immunopathogenesis of multiple sclerosis. A survey of recent advances and implications for future therapy. Kieseier BC, Archelos JJ, Storch M, Gold R, Hartung HP. Wien Klin Wochenschr; 1999 Sep 17; 111(17):728-37. PubMed ID: 10526397 [Abstract] [Full Text] [Related]
30. Multiple sclerosis and virus induced immune responses: autoimmunity can be primed by molecular mimicry and augmented by bystander activation. McCoy L, Tsunoda I, Fujinami RS. Autoimmunity; 2006 Feb 17; 39(1):9-19. PubMed ID: 16455578 [Abstract] [Full Text] [Related]
31. Immunotoxicity profile of natalizumab. Wehner NG, Gasper C, Shopp G, Nelson J, Draper K, Parker S, Clarke J. J Immunotoxicol; 2009 Jun 17; 6(2):115-29. PubMed ID: 19589098 [Abstract] [Full Text] [Related]
32. Multiple sclerosis. Hafler DA, Slavik JM, Anderson DE, O'Connor KC, De Jager P, Baecher-Allan C. Immunol Rev; 2005 Apr 17; 204():208-31. PubMed ID: 15790361 [Abstract] [Full Text] [Related]
33. Immune surveillance of the human central nervous system (CNS): different migration pathways of immune cells through the blood-brain barrier and blood-cerebrospinal fluid barrier in healthy persons. Kleine TO, Benes L. Cytometry A; 2006 Mar 17; 69(3):147-51. PubMed ID: 16479603 [Abstract] [Full Text] [Related]
35. PSGL-1--the hidden player in T cell trafficking into the brain in multiple sclerosis? Engelhardt B. J Leukoc Biol; 2009 Nov 17; 86(5):1023-5. PubMed ID: 19875629 [No Abstract] [Full Text] [Related]
37. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Engelhardt B, Ransohoff RM. Trends Immunol; 2005 Sep 17; 26(9):485-95. PubMed ID: 16039904 [Abstract] [Full Text] [Related]
38. Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease. Trabattoni D, Saresella M, Pacei M, Marventano I, Mendozzi L, Rovaris M, Caputo D, Borelli M, Clerici M. J Immunol; 2009 Oct 15; 183(8):4984-93. PubMed ID: 19794071 [Abstract] [Full Text] [Related]